Search research articles
Contact Us
Filters
Showing results (181-190 of 471) with videos related to
Page
of 48
Sort By:
Nuclear Medicine Communications
|
April 9, 2010
The evolving role of PET/CT in breast cancer
David Groheux, Sylvie Giacchetti, Domenico Rubello, et al.
Clinical Nuclear Medicine
|
July 16, 2019
In Vivo Microbial Targeting of 99mTc-Labeled Human β-Defensin-3 in a Rat Model of Infection
Giulia Anna Follacchio, Alessandro Pala, Sergio Scaccianoce, et al.
Nuclear Medicine Communications
|
April 7, 2007
68Ga-DOTATATE PET in neuroectodermal tumours: first experience
Zarni Win, Adil Al-Nahhas, David Towey, et al.
Nuclear Medicine Communications
|
March 6, 2009
The Response Evaluation Criteria in Solid Tumors: until when?
Margherita Nannini, Maria Abbondanz Pantaleo, Alessandra Maleddu, et al.
Cancer Biotherapy & Radiopharmaceuticals
|
December 30, 2008
(18)F-FDG PET in Pediatric Lymphomas: A Comparison with Conventional Imaging
Egesta Lopci, Roberta Burnelli, Valentina Ambrosini, et al.
European Journal of Radiology
|
February 8, 2011
Evaluation of incidentally discovered adrenal masses with PET and PET/CT
Ka Kit Wong, Mohammad Arabi, Wessam Bou-Assaly, et al.
Nuclear Medicine Communications
|
October 30, 2015
Is there a role for PET/CT in the evaluation of primary and secondary hyperparathyroidism?
David Fuster, José-Vicente Torregrosa, Francisco Campos, et al.
International Journal of Cardiology
|
April 4, 2016
Differentiation of cardiac thrombus from cardiac tumor combining cardiac MRI and 18F-FDG-PET/CT Imaging
Massimo Rinuncini, Marco Zuin, Fiorenzo Scaranello, et al.
Nuclear Medicine Communications
|
April 9, 2016
Cerebral metabolic rate of glucose quantification with the aortic image-derived input function and Patlak method: numerical and patient data evaluation
Eleonora Vanzi, Valentina Berti, Cristina Polito, et al.
Clinical Nuclear Medicine
|
July 17, 2013
Incidental detection of Leydig cell tumor via fluorine-18-Choline PET/CT in a patient with recurrent prostate cancer disease
Marino Cimitan, Marina Hodolič, Anna Margherita Maffione, et al.
Page
of 48
Search research articles
Search
Showing results (181-190 of 471) with videos related to
Sort By:
Page
of 48
Nuclear Medicine Communications
|
April 9, 2010
The evolving role of PET/CT in breast cancer
David Groheux, Sylvie Giacchetti, Domenico Rubello, et al.
Clinical Nuclear Medicine
|
July 16, 2019
In Vivo Microbial Targeting of 99mTc-Labeled Human β-Defensin-3 in a Rat Model of Infection
Giulia Anna Follacchio, Alessandro Pala, Sergio Scaccianoce, et al.
Nuclear Medicine Communications
|
April 7, 2007
68Ga-DOTATATE PET in neuroectodermal tumours: first experience
Zarni Win, Adil Al-Nahhas, David Towey, et al.
Nuclear Medicine Communications
|
March 6, 2009
The Response Evaluation Criteria in Solid Tumors: until when?
Margherita Nannini, Maria Abbondanz Pantaleo, Alessandra Maleddu, et al.
Cancer Biotherapy & Radiopharmaceuticals
|
December 30, 2008
(18)F-FDG PET in Pediatric Lymphomas: A Comparison with Conventional Imaging
Egesta Lopci, Roberta Burnelli, Valentina Ambrosini, et al.
European Journal of Radiology
|
February 8, 2011
Evaluation of incidentally discovered adrenal masses with PET and PET/CT
Ka Kit Wong, Mohammad Arabi, Wessam Bou-Assaly, et al.
Nuclear Medicine Communications
|
October 30, 2015
Is there a role for PET/CT in the evaluation of primary and secondary hyperparathyroidism?
David Fuster, José-Vicente Torregrosa, Francisco Campos, et al.
International Journal of Cardiology
|
April 4, 2016
Differentiation of cardiac thrombus from cardiac tumor combining cardiac MRI and 18F-FDG-PET/CT Imaging
Massimo Rinuncini, Marco Zuin, Fiorenzo Scaranello, et al.
Nuclear Medicine Communications
|
April 9, 2016
Cerebral metabolic rate of glucose quantification with the aortic image-derived input function and Patlak method: numerical and patient data evaluation
Eleonora Vanzi, Valentina Berti, Cristina Polito, et al.
Clinical Nuclear Medicine
|
July 17, 2013
Incidental detection of Leydig cell tumor via fluorine-18-Choline PET/CT in a patient with recurrent prostate cancer disease
Marino Cimitan, Marina Hodolič, Anna Margherita Maffione, et al.
Page
of 48